NOTE 1. ORGANIZATION

Organization

Healthier Choices Management Corp. (the “Company” or “HCMC”) is a holding company focused on monetizing its intellectual property through its wholly owned subsidiary, HCMC Intellectual Property Holdings, LLC. The Company seeks to further monetize its patent suite through development and production of its patented products, including the Q-Cup™ technology and Imitine, licensing and royalty agreements, and enforcement actions against infringers of its intellectual property.

The Company administers and intends to augment its intellectual property portfolio via its wholly owned subsidiary, HCMC Intellectual Property Holdings, LLC.

The Company continues to promote its patented Q-Cup™ technology directly to consumers in the vaping market. This cutting-edge design includes a small quartz cup that users can fill with cannabis or CBD concentrate. Once placed in a Q-Cup™ Tank or Globe, the cup is heated externally without direct contact with the concentrate. This innovative approach provides greater efficiency and a convenient solution for consumers who vape concentrates for both medicinal and recreational use.

In connection with the Company’s strategic initiative to monetize its intellectual property through the development and production of new products, the Company entered into a Distribution Agreement (the “Distribution Agreement”) with a third party distributor on November 27, 2025, to commercialize a new product line utilizing the Company’s NatureTine™ ingredient (the “Quitcubes” product line). Under the Distribution Agreement, the distributor is responsible for marketing, customer fulfillment, and website management, while the Company is responsible for manufacturing the product.

The launch of the Quitcubes product line, originally anticipated to commence in the first quarter of 2026, was delayed as the Company worked to establish the necessary operational infrastructure to execute the Distribution Agreement. As a result, the Company recorded no net sales from the Quitcubes product line for the three and six months ended June 30, 2026.

Subsequent to June 30, 2026, the Company has made significant progress in establishing the required operational infrastructure. Management is now working with the distributor to finalize the remaining steps and expects the official commercial launch of the Quitcubes product line to occur in the third quarter of 2026. However, there can be no assurance that the launch will occur as planned, or if launched, that the product line will generate material revenue or positive cash flow.

Segment Reporting

Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision makers, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company operates as a single reportable segment, as the chief operating decision maker (“CODM”, the Company’s Chief Executive Officer, Jeffrey Holman) reviews financial performance and makes decisions on a consolidated basis.

NOTE 2. GOING CONCERN AND MANAGEMENT’S PLANS

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.

The Company currently and historically has reported net losses and cash outflows from operations. As of June 30, 2026, the Company had cash and cash equivalent of approximately $1.2 million and negative working capital of $0.7 million. The Company’s liquidity needs through June 30, 2026 have been satisfied through financing agreement with private lenders.

On March 27, 2026, the Company entered into a $5 million loan agreement with Sabby Volatility Warrant Master Fund, Ltd. (the “Sabby Loan Agreement”). Concurrently, the Company terminated its prior $5 million credit facility with a private lender. In connection with the Sabby Loan Agreement, the Company received an initial advance of $500,000. The remaining $4.5 million is available to the Company subject to the terms and conditions of the Sabby Loan Agreement.

On June 26, 2026, the Company received $50,000 in cash proceeds from Pinz Capital Special Opportunities Fund, LP in connection with a convertible promissory note. The formal loan agreement was executed on July 6, 2026. The note matures on May 5, 2030, bears interest at 12% per annum, with principal and interest due in ten equal monthly installments beginning on the third anniversary of issuance, subject to earlier conversion. The proceeds from this note provided additional liquidity to support the Company’s operations.

Management has made plans to reduce certain costs and raise needed capital, however there can be no assurance the Company can successfully implement these plans. The success of these plans is dependent upon various factors, foremost being the ability to reduce outside consulting expenses and the ability to secure additional capital from outside investors. There can be no assurance that such plans will be successful.

Management believes that the Company’s cash on hand, together with the availability of up to $4.5 million in additional draws under the Sabby Loan Agreement, and the $50,000 in proceeds from the June 26, 2026 convertible note, will enable the Company to meet its obligations and capital requirements for at least the twelve months from the date of this filing. Accordingly, no adjustment has been made to the financial statements to account for this uncertainty.

NOTE 3. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

NOTE 4. CONCENTRATIONS

Cash, Cash Equivalent and Restricted Cash

The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalent. The majority of the Company’s cash and cash equivalent are concentrated in one large financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage.

The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company has not experienced any losses in such accounts.

Restricted Cash

The Company’s restricted cash consisted of cash balances which were restricted as to withdrawal or usage under the August 18, 2022 Securities Purchase Agreement for the purpose of funding any amounts due under the Series E Certificate of Designation upon the redemption of the Series E Preferred Stock.

NOTE 5. PROPERTY AND EQUIPMENT

The Company incurred approximately $2,000 of depreciation expense for the three months ended June 30, 2026 and 2025, and approximately $4,000 of depreciation expense for the six months ended June 30, 2026 and 2025, respectively.

NOTE 6. INTANGIBLE ASSETS

Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense was approximately $10,000 and $11,000 for the three months ended June 30, 2026 and 2025, and $20,000 and $22,000 for the six months ended June 30, 2026 and 2025, respectively. Future annual estimated amortization expense is as follows:

NOTE 7. DEBT

Private Lender Credit Facility

On November 7, 2024, the Company entered into a $5,000,000 revolving line of credit agreement with a private lender (the “Prior Facility”). The Prior Facility bore interest at 12% per annum, payable quarterly, and was scheduled to mature on April 30, 2026. On April 11, 2025, the Company and the lender amended the agreement to extend the maturity date to December 31, 2026. On March 27, 2026, the Company terminated the Prior Facility. No amounts were outstanding under the Prior Facility at the time of termination.

Sabby Volatility Warrant Master Fund, Ltd. Credit Facility

On March 27, 2026, the Company entered into a Loan Agreement (the “Sabby Loan Agreement”) with Sabby Volatility Warrant Master Fund, Ltd. (the “Lender”), providing for a $5,000,000 unsecured revolving line of credit. The Sabby Facility matures on December 31, 2026, unless extended at the Lender’s sole discretion. Borrowings under the Sabby Facility bear interest at 12% per annum. Interest is payable on the Maturity Date, together with the outstanding principal balance. The Company may request advances from time to time, subject to the terms and conditions of the Sabby Loan Agreement. In connection with the initial funding under the Sabby Facility, the Company received an advance of $500,000 (the “Initial Advance”).

As of June 30, 2026, the outstanding principal balance under the Sabby Facility was $500,000. The remaining $4,500,000 is available for future advances, subject to the terms and conditions of the Sabby Loan Agreement. Interest expense for the three months ended June 30, 2026 was approximately $15,000, compared to approximately $0 for the same period in 2025. Interest expense for the six months ended June 30, 2026 was approximately $16,000, compared to approximately $0 for the same period in 2025. Interest expense is recognized as incurred based on the outstanding principal balance and the contractual interest rate.

Promissory Note

On February 1, 2026, the Company entered into a Stock Purchase and Satisfaction of Debt Agreement with a legal vendor to settle outstanding amount in excess of $1.4 million. In connection with this agreement, the Company issued $875,000 promissory note to this legal vendor. The Note is non-interest-bearing and has no fixed maturity date. The principal amount of $875,000 becomes due immediately upon the first occurrence of any of the following events:

The note is classified as a current liability and recorded at face value. The issuance of the Note was a non-cash financing activity. Accordingly, it has been excluded from the statement of cash flows and disclosed in the supplemental schedule of non-cash investing and financing activities.

Convertible Promissory Note

On June 26, 2026, the Company received $50,000 in cash proceeds from Pinz Capital Special Opportunities Fund, LP in connection with a convertible promissory note. The formal loan agreement was executed on July 6, 2026. The note matures on May 5, 2030 and bears interest at 12% per annum, with principal and interest due in ten equal monthly installments beginning on the third anniversary of issuance, subject to earlier conversion. The Holder may convert principal and accrued interest at any time into common stock at $0.00009 per share, subject to a 9.9% beneficial ownership cap, resulting in approximately 555.6 million shares issuable upon full conversion of principal alone. In connection with the note, the Company also issued the Holder a warrant to purchase 250,000,000 shares of common stock. The note is unsecured and contains customary default provisions, including a share reserve requirement, transfer agent reserve letter, and default interest rate of up to 18% per annum.

NOTE 8. STOCKHOLDERS’ EQUITY

Series E Convertible Preferred Stock

On August 18, 2022, the Company entered into a Securities Purchase Agreement (“Series E Preferred Stock”) pursuant to which the Company sold and issued 14,722 shares of its Series E Redeemable Convertible Preferred Stock to institutional investors for $1,000 per share or an aggregate subscription of $13.25 million. The number of shares issued to each participant is based on subscription amount multiplied by conversion rate of 1.1111. The Company also incurred offering costs of approximately $410,000, which covers legal and consulting fee.

The HCMC Series E Preferred Stock shall have voting rights on as converted basis at the Company’s next stockholders’ meeting. However, as long as any shares of HCMC Series E Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of the HCMC Series E Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the HCMC Series E Preferred Stock or alter or amend the Certificate of Designation, (b) increase the number of authorized shares of HCMC Series E Preferred Stock, or (c) enter into any agreement with respect to any of the foregoing. Each share of Series E Preferred Stock shall be convertible, at any time and from time to time at the option of the Holder thereof, into that number of shares of Common Stock (subject to the beneficial ownership limitations). The initial conversion price for the HCMC Series E Preferred Stock shall equal $0.0001.

Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary that is not a Fundamental Transaction (as defined in the Certificate of Designation), the holders of HCMC Series E Preferred Stock shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to $1,000 per share of Series E Preferred Stock.

Unless earlier converted or extended as set forth below, a holder may require the redemption of all or a portion of the stated value of the HCMC Series E Preferred Stock either (1) six months after closing or (2) the time at which the balance is due and payable upon an event of default.

On March 1, 2023, the Company entered into a First Amendment to HCMC Series E Preferred Stock with each purchaser (“Purchaser”) identified as those who participated in the HCMC Series E Preferred Stock, dated as of August 18, 2022. The parties amended the HCMC Preferred Stock related to the conversion payment whereby upon conversion of the Series E Preferred Stock prior to the record date for the Spin-Off, the Company will pay the Purchaser ten percent (10%) of the stated value of the Series E Preferred Stock converted. The record date is May 1, 2023.

On May 15, 2023, the Company and the Purchaser entered into the Second Amendment to the Securities Purchase Agreement, pursuant to which the Company agreed to extend the time period for the Conversion Payment eligibility to December 1, 2023. The Company filed an amendment to the Certificate of Designation to make the redemption price of the Preferred Stock (the “Redemption Price”) equal the Stated Value regardless of the date on which it is redeemed. Prior to this amendment, the Redemption Price was discounted by 1% for each month after the seven-month anniversary of the Issue Date that the Purchaser elected not to redeem.

On October 30, 2023, the Company entered into a Third Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers. The parties agreed to: (1) set the initial conversion price for the Series E Preferred Stock to be the 5-day volume weighted average price measured using the 5 trading days preceding the purchase of the Series E Preferred Stock, (2) on the 40th calendar day (the “Reset Date”) after the sale of the Series E Preferred Stock, reset the conversion price in the event the closing price of the Class A common stock on such date is less than the initial conversion, (3) have the reset conversion price equal a 10% discount to the 5-day volume weighted average price measured using the 5 trading days preceding the Reset Date; provided, however, in no instance will the conversion price be reset below 30% of the initial conversion price, and (4) amend the date on which the obligation to acquire the Series E Preferred Stock ceases to March 1, 2024.

On February 20, 2024, the Company entered into a Fourth Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers, pursuant to which the Company and such parties agreed to amend the date on which the obligation to acquire the Series E Preferred Stock ceases to June 1, 2024.

On April 8, 2024, the Company entered into a Fifth Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers, pursuant to which the Company and such parties agreed to amend the Completion Date to August 1, 2024.

On July 26, 2024, the Company entered into a Sixth Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers, pursuant to which the Company and such parties agreed to amend the Completion Date to November 1, 2024.

On November 27, 2024, the Company entered into a Seventh Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers, pursuant to which the Company and such parties agreed to amend the Completion Date to May 31, 2025.

On April 11, 2025, the Company entered into an Eighth Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers, pursuant to which the Company and such parties agreed to amend the Completion Date to October 31, 2025.

On October 30, 2025, the Company entered into a Ninth Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers, pursuant to which the Company and such parties agreed to amend the Completion Date to April 1, 2027.

Through June 30, 2026, 1,585 shares of Series E preferred stock have been cumulatively converted into 15,850,000,000 shares of common stock as a result of the Series E preferred stock conversion, and 12,026 shares of Series E preferred stock have been cumulatively redeemed, and approximately $12,004,000 has been paid for redemption. As of June 30, 2026, 1,111 shares of Series E preferred stock remained outstanding.

Stock Options and Restricted Stock

During the three and six months ended June 30, 2026 and 2025, no stock options of the Company were exercised into common stock.

The Company recognized stock-based compensation of approximately $0 and $1,123,000 during the three months ended June 30, 2026 and 2025, and approximately $0 and $2,245,000 during the six months ended June 30, 2026 and 2025, respectively in connection with amortization of restricted stock and stock options. Stock based compensation is included as part of total operating expenses in the accompanying unaudited condensed consolidated statements of operations.

Warrants Granted for Services

On April 24, 2026, the Company entered into a Consulting Agreement with Active Ventures, LLC (the “Consultant”) to provide services related to developing a crypto acquisition strategy over a three-year consulting term. In consideration for these services, the Company granted the Consultant Pre-Funded Warrants to purchase up to 30,000,000,000 shares of common stock, exercisable at $0.0001 per share. The warrants vest in 12 equal tranches of 2,500,000,000 shares each, with Tranche 1 vesting on April 24, 2026, and the remaining tranches vesting at subsequent intervals over 33 months.

The warrants were valued at approximately $30,000 in the aggregate based on their grant-date fair value using the Black-Scholes option pricing model. Since the warrants were granted to a nonemployee, the graded vesting method is mandatory under ASC 718. Accordingly, compensation cost for each tranche is recognized over its respective vesting period. For the three and six months ended June 30, 2026, the Company recognized consulting expenses of approximately $8,000, representing the portions of all 12 tranches earned during the period. The expense is included in operating expenses in the accompanying condensed consolidated statements of operations. As of June 30, 2026, the warrants remained outstanding and unexercised, with Tranche 1 fully vested and Tranches 2 through 12 unvested.

Debt Settlement through Issuance of Common Stock

On December 31, 2025, the Company entered into a Stock Purchase and Satisfaction of Debt Agreement with Healthy Choice Wellness Corp. (“HCWC”), a related party. Pursuant to this agreement, the Company issued 43,889,786,222 shares of its common stock to HCWC at a contractual price of $0.00009 per share, in full and final settlement of a related party payable, which had a carrying value of $3,950,080 as of the settlement date. In accordance with the Company’s accounting policy for related party transactions, the payable was extinguished at its carrying amount, and no gain or loss was recognized.

On February 1, 2026, the Company entered into a settlement agreement with a vendor to resolve approximately $1.3 million in outstanding accounts payable for past services. Under the terms of the agreement, the total obligation was reduced to $875,000, and the Company issued a non-interest bearing promissory note in that amount to the vendor. The remaining balance of the original obligation was satisfied through a combination of (i) the issuance of 2,000,000,000 shares of the Company’s common stock valued at $0.0001 per share, totaling $200,000, and (ii) the recharacterization of a portion of the obligation as part of a contingent fee arrangement related to ongoing patent litigation.

Earning Per Share

Basic earnings per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards. For the three and six months ended June 30, 2026 and 2025, diluted EPS is the same as basic EPS because all potentially dilutive securities are anti-dilutive. Under GAAP, diluted EPS must be disclosed even when equal to basic EPS. All potentially dilutive securities were excluded from the diluted EPS calculation because their inclusion would have been anti-dilutive (i.e., reduce the loss per share), which is not permitted under GAAP.

NOTE 9. COMMITMENTS AND CONTINGENCIES

Legal Proceedings

There were two lawsuits in connection with alleged claimed battery defects for an electronic cigarette device. One has been dismissed by the court wherein the plaintiff settled with the Company’s insurance carrier with no economic impact to the Company. In the second lawsuit, as of December 31, 2023, the Company had reached an arrangement with the plaintiff to resolve the matter, limiting potential exposure to $1.5 million which was reflected in accounts payable and accrued expenses, representing management’s estimate of the probable settlement amount based on the current status of discussions. This arrangement was formalized by a signed agreement on July 1, 2024 and the Company has accrued $1.5 million at June 30, 2024. As of May 31, 2025, the Company already paid $1.5 million in full.

On September 26, 2023, HCMC filed a patent infringement lawsuit against R.J. Reynolds Vapor Company (“RJR”) in the U.S. District Court for the Middle District of North Carolina in connection with HCMC’s assertions that RJR’s Vuse electronic cigarette infringes one of HCMC’s patents.

On November 17, 2023, RJR filed a motion to dismiss the action. HCMC opposed on December 22, 2023.

On September 18, 2024, RJR filed an inter partes review of the patent-in-suit at the United States Patent and Trademark Office (“USPTO”).

In March 2026, the Patent Trial and Appeal Board issued a decision in favor of RJR in the ongoing patent dispute. On June 1, 2026, HCMC filed an appeal to the ruling in the U.S. Court of Appeals for the Federal Circuit.

From time to time the Company is involved in legal proceedings arising in the ordinary course of our business. We believe that there is no other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations as of June 30, 2026. With respect to legal costs, we record such costs as incurred.

NOTE 10. RELATED PARTY TRANSACTIONS

Prior to the Spin-Off, HCWC was a subsidiary of HCMC. Following the Spin-Off on September 13, 2024, the Company and HCWC operate as separate, publicly traded companies, though they remain related parties due to common ownership history and ongoing agreements.

Due to Related Party

Prior to the Spin-Off, there was no intercompany agreement between the Company and HCWC. Management has determined that intercompany receivables and payables will be settled within twelve months after the balance sheet date. As a result, the Company’s intercompany balances are reflected as “due to” or “due from” accounts in the consolidated balance sheets. After the Spin-Off, the Company and HCWC provided services to each other pursuant to the separation agreements to facilitate a smooth transition. The Company had a net due to related party balance of $0.2 million and $0 million to HCWC as of June 30, 2026 and December 31, 2025, respectively.

Settlement of Related Party Payable

On December 31, 2025, the Company entered into a Stock Purchase and Satisfaction of Debt Agreement with HCWC to settle the outstanding related party payable. Pursuant to this agreement, the Company issued 43,889,786,222 shares of its common stock to HCWC in full and final settlement of the payable, which had a carrying value of $3,950,080 as of the settlement date. The shares were issued at a contractual price of $0.00009 per share.

In accordance with ASC 850, Related Party Disclosures, and SAB Topic 5.T, transactions involving related parties are recorded based on their substance rather than merely their legal form. Related party transactions cannot be presumed to be carried out on an arm’s-length basis. Accordingly, the payable was extinguished at its carrying amount of $3,950,080, and no gain or loss was recognized. The substance of this transaction is a capital transaction, a conversion of intercompany funding to equity, not a gain-generating event.

For disclosure purposes only, the Company determined the fair value of the common stock issued as of December 31, 2025 in accordance with ASC 820, Fair Value Measurement. HCWC, as the investor, performed an impairment assessment of its investment in the Company using a third-party valuation. That assessment, which utilized a multi-method approach including observable and unobservable inputs, concluded that the fair value of the Company’s common stock exceeded HCWC’s carrying value; therefore, no impairment was recorded.

Agreements with HCWC

The Company entered into several agreements with HCWC that, among other things, affect the separation and govern the relationship of the parties following the Spin-Off. These agreements include:

Termination of Transition Services Agreement

On August 10, 2026, the Company and HCWC entered into a Termination Agreement, which formally terminated the TSA effective as of January 1, 2026. The Termination Agreement provides for a mutual release of any liability or obligation under the TSA from and after the effective date. As a result, no further services will be provided by the Company to HCWC under the TSA. Management determined that the payroll costs primarily benefited HCWC and that the corresponding liability was legally extinguished. Accordingly, during the three months ended June 30, 2026, the Company reclassified the payroll expense and recognized a reduction in operating expenses of $328,373. This reclassification is presented as “Reclassification of payroll expense – TSA termination” in the accompanying condensed consolidated statements of operations.

NOTE 11. SUBSEQUENT EVENTS

In accordance with FASB ASC 855-10, the Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements were available to be issued. Based upon this review, the Company identified the following subsequent event that would have required disclosure in the condensed consolidated financial statements.

Digital Asset Initiative

On June 30, 2026, the Company publicly announced a new initiative to pursue opportunities in the digital asset ecosystem through its RAGE (Risk Assessment Gauging Enterprise) platform. On July 1, 2026 and July 8, 2026, the Company announced the acquisition of two digital tokens in connection with this initiative. As of the date of this filing, these tokens have not been delivered to the Company. No cash consideration has been paid, and no asset has been recognized on the balance sheet.

Subsequent to the balance sheet date, management has been actively evaluating this initiative in light of the Company’s current liquidity position, the volatility and regulatory uncertainties associated with the digital asset ecosystem, and the Company’s core strategic objectives. The Company will account for the tokens upon delivery in accordance with ASU 2023-08, which requires crypto assets within its scope to be measured at fair value with changes recognized in earnings. There can be no assurance that the tokens will be delivered, or if delivered, that they will generate any future revenue or positive cash flow.

Convertible Promissory Note

On July 6, 2026, the Company issued a convertible promissory note to Pinz Capital Special Opportunities Fund, LP in the principal amount of $50,000, maturing May 5, 2030. The note bears interest at 12% per annum, payable in kind, with principal and interest due in ten equal monthly installments beginning on the third anniversary of issuance, subject to earlier conversion. The Holder may convert principal and accrued interest at any time into common stock at $0.00009 per share, subject to a 9.9% beneficial ownership cap, resulting in approximately 555.6 million shares issuable upon full conversion of principal alone. In connection with the note, the Company also issued the Holder a warrant to purchase 250,000,000 shares of common stock. The note is unsecured and contains customary default provisions, including a share reserve requirement, transfer agent reserve letter, and default interest rate of up to 18% per annum.

Termination of Transition Services Agreement

On August 10, 2026, the Company and HCWC entered into a Termination Agreement, which formally terminated the Transition Services Agreement effective as of January 1, 2026. The Termination Agreement provides for a mutual release of any liability or obligation under the TSA from and after the effective date. As a result, no further services will be provided by the Company to HCWC under the TSA, and all outstanding balances thereunder will be settled in the normal course of business. See Note 10 – Related Party Transactions for additional information.